| 摘要 |
Use of a bactericidal/permeability-increasing (BPI) protein product for the manufacture of a medicament for the treatment of chronic cardiac disease. Use of a BPI protein product for preparation of a medicament for treating a human suffering from a chronic cardiac disease state, wherein the human exhibits elevated levels of circulating LBP. A method of treating a non-human mammal with chronic disease, comprising the step of administering a therapeutically effective amount of a BPI protein product to the animal.
|
